Delivery Order SPE2DP23D0001-SPE2D625F4QK3
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a $2,090.49 firm fixed-price delivery order (Contract No. 4568409126) to Canadian Commercial Corporation (CCC) on May 30, 2025, with an ultimate completion date of August 14, 2025. This delivery order, which carries no set-aside designation, represents a task order under CCC's existing contract vehicle and leverages the corporation's established government-to-government contracting relationship with U.S. defense agencies. CCC, a Crown...
- The U.S. Department of Defense's Medical Supply Chain awarded a $104.5K delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for Reactive Skin Decontamination Lotion. This contract represents a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and carries no set-aside designation. The work will be performed in Ottawa, Ontario, Canada, reflecting CCC's role as a Crown corporation that serves as an intermediary facilitating...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for the supply of Inactive Skin Decontamination Lotion 21. This contract, valued at $1,648.86, is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025. The contract carries no set-aside designation, reflecting CCC's role as a Crown corporation facilitating government-to-government contracting between U.S. federal agencies and...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $41,221.50 to Canadian Commercial Corporation (CCC) on October 2, 2025, for Inactive Skin Decontamination Lotion 21. This contract is a child delivery order under a larger indefinite delivery vehicle and utilizes firm fixed-price pricing with no set-aside designation. Performance will be completed by December 18, 2025, with work to be performed at CCC's facility in Ottawa, Ontario, Canada. The Reactive...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Canadian Commercial Corporation (CCC), a Crown corporation of the Government of Canada, for Reactive Skin Decontamination Lotion. The contract has a potential value of $308,000.00 and a completion date of July 12, 2017. It is a Firm Fixed Price contract with no set-aside designation. As the prime contractor, CCC has subcontracted with Emergent Biosolutions Canada Inc., a for-profit...
- This is a $31,196.40 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. The contract has a completion date of March 7, 2024 and does not have a set-aside designation. CCC has provided a wide range of goods and services to U.S. federal agencies,...
- This is a $4,180.98 firm fixed-price delivery order awarded by the U.S. Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada that serves as a prime contractor to U.S. federal agencies. The contract is for the delivery of Reactive Skin Decontamination Lotion, a medical supply item, with a period of performance through September 23, 2025. This contract does not utilize a set-aside designation. CCC is a strategic supplier...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract to the Canadian Commercial Corporation (CCC), a Crown corporation of the Government of Canada, for $39,564.00. The contract has a completion date of February 22, 2024 and was awarded on December 6, 2023. CCC is acting as the prime contractor and will be delivering medical supplies, potentially including skin decontamination lotion, to support U.S. federal agencies. This order is...
- This $4,159.52 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada. CCC is serving as the prime contractor to provide skin decontamination lotion. The work will be performed in Ottawa, Ontario, Canada. The contract is not associated with a set-aside designation. CCC has a history of providing a wide range of goods and services to U.S. federal...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Canadian Commercial Corporation, for $760,656.00. The contract is for the provision of Reactive Skin Decontamination Lotion, with the place of performance located in Ottawa, Canada. Canadian Commercial Corporation is a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. As a...
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D625F4QK3Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $747.8K delivery order to Canadian Commercial Corporation (CCC) on July 1, 2025, with completion targeted for September 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, leverages CCC's government-to-government contracting model to procure Reactive Skin Decontamination Lotion from subcontractor Emergent Biosolutions Canada Inc. The product will be performed at CCC's facility in Ottawa, Ontario. As a Crown corporation owned by the Government of Canada, CCC serves as an established intermediary facilitating U.S. federal access to Canadian manufacturing capabilities, particularly for defense-related medical supplies and specialized equipment. Emergent Biosolutions Canada Inc., the primary subcontractor, is a recognized supplier of medical countermeasures to the U.S. government, specializing in therapeutics and vaccines against chemical, biological, radiological, and nuclear threats. The Reactive Skin Decontamination Lotion supplied under this order represents a critical component of the Defense Logistics Agency's medical supply inventory for chemical defense applications. This delivery order reflects the continued strategic partnership between U.S. defense agencies and Canadian commercial entities in securing essential protective medical supplies through established procurement channels.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
105929634S | Emergent Biosolutions Canada Inc. | Delivery Order SPE2DP23D0001-SPE2D625F4QK3 | $0 | 7/1/25 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $747.8k | 7/1/25 |